United States Recombinant Immunotherapeutics Market Report 2021

August 2016 | 102 pages | ID: UC7FD237621EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Recombinant Immunotherapeutics

Revenue, means the sales value of Recombinant Immunotherapeutics

This report studies sales (consumption) of Recombinant Immunotherapeutics in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Amgen
• AstraZeneca
• Baxter
• Britannia
• Capricor
• CSL Behring
• GlaxoSmithKline
• Grifols
• Ferring
• Janssen
• NeuroDerm
• Octapharma
• Roche
• Rhythm Metabolic
• scPharmceuticals
• SteadyMed
• Takeda
• United Therapeutics
• UCB
• US Worldmeds

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Recombinant Immunotherapeutics in each application, can be divided into

• Medical care
• Hospital
• Application 3

Contents

United States Recombinant Immunotherapeutics Market Report 2021

1 RECOMBINANT IMMUNOTHERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Recombinant Immunotherapeutics
1.2 Classification of Recombinant Immunotherapeutics
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Recombinant Immunotherapeutics
  1.3.1 Medical care
  1.3.2 Hospital
  1.3.3 Application
1.4 USA Market Size (Value and Volume) of Recombinant Immunotherapeutics (2011-2021)
  1.4.1 USA Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
  1.4.2 USA Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
  1.4.3 USA Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)

2 USA RECOMBINANT IMMUNOTHERAPEUTICS COMPETITION BY MANUFACTURERS

2.1 USA Recombinant Immunotherapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Recombinant Immunotherapeutics Revenue and Share by Manufactures (2015 and 2016)

3 USA RECOMBINANT IMMUNOTHERAPEUTICS (VOLUME AND VALUE) BY TYPE

3.1 USA Recombinant Immunotherapeutics Sales and Market Share by Type (2011-2021)
3.2 USA Recombinant Immunotherapeutics Revenue and Market Share by Type (2011-2021)

4 USA RECOMBINANT IMMUNOTHERAPEUTICS (VOLUME) BY APPLICATION

5 USA RECOMBINANT IMMUNOTHERAPEUTICS MANUFACTURERS ANALYSIS

5.1 Amgen
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Recombinant Immunotherapeutics Product Type and Technology
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Amgen (2015 and 2016)
5.2 AstraZeneca
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pharmaceuticals Sales, Revenue, Price of AstraZeneca (2015 and 2016)
5.3 Baxter
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Baxter Product Type and Technology
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Baxter Sales, Revenue, Price of Baxter (2015 and 2016)
5.4 Britannia
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Ferring Product Type and Technology
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Britannia Sales, Revenue, Price of Britannia (2015 and 2016)
5.5 Capricor
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Capricor Product Type and Technology
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Capricor Sales, Revenue, Price of Capricor (2015 and 2016)
5.6 CSL Behring
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 CSL Behring Product Type and Technology
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 CSL Behring Sales, Revenue, Price of CSL Behring (2015 and 2016)
5.7 GlaxoSmithKline
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 GlaxoSmithKline Product Type and Technology
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
5.8 Grifols
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 Grifols Product Type and Technology
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Grifols Sales, Revenue, Price of Grifols (2015 and 2016)
5.9 Ferring
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Ferring Product Type and Technology
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Ferring Sales, Revenue, Price of Ferring (2015 and 2016)
5.10 Janssen
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Janssen Product Type and Technology
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Janssen Sales, Revenue, Price of Janssen (2015 and 2016)
5.11 NeuroDerm
5.12 Octapharma
5.13 Roche
5.14 Rhythm Metabolic
5.15 scPharmceuticals
5.16 SteadyMed
5.17 Takeda
5.18 United Therapeutics
5.19 UCB
5.20 US Worldmeds

6 RECOMBINANT IMMUNOTHERAPEUTICS TECHNOLOGY AND DEVELOPMENT TREND

6.1 Recombinant Immunotherapeutics Technology Analysis
6.2 Recombinant Immunotherapeutics Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Immunotherapeutics
Table Classification of Recombinant Immunotherapeutics
Figure USA Sales Market Share of Recombinant Immunotherapeutics by Type in 2015
Table Applications of Recombinant Immunotherapeutics
Figure USA Sales Market Share of Recombinant Immunotherapeutics by Application in 2015
Figure Medical care Examples
Figure Hospital Examples
Table USA Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
Figure USA Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
Figure USA Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Table USA Recombinant Immunotherapeutics Sales of Key Manufacturers (2015 and 2016)
Table USA Recombinant Immunotherapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Immunotherapeutics Sales Share by Manufacturers
Figure 2016 Recombinant Immunotherapeutics Sales Share by Manufacturers
Table USA Recombinant Immunotherapeutics Revenue by Manufacturers (2015 and 2016)
Table USA Recombinant Immunotherapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Recombinant Immunotherapeutics Revenue Share by Manufacturers
Table 2016 USA Recombinant Immunotherapeutics Revenue Share by Manufacturers
Table USA Recombinant Immunotherapeutics Sales and Market Share by Type (2011-2021)
Table USA Recombinant Immunotherapeutics Sales Share by Type (2011-2021)
Figure Sales Market Share of Recombinant Immunotherapeutics by Type (2011-2021)
Figure USA Recombinant Immunotherapeutics Sales Growth Rate by Type (2011-2021)
Table USA Recombinant Immunotherapeutics Revenue and Market Share by Type (2011-2021)
Table USA Recombinant Immunotherapeutics Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Recombinant Immunotherapeutics by Type (2011-2021)
Figure USA Recombinant Immunotherapeutics Revenue Growth Rate by Type (2011-2021)
Table USA Recombinant Immunotherapeutics Sales and Market Share by Application (2011-2021)
Table USA Recombinant Immunotherapeutics Sales Share by Application (2011-2021)
Figure Sales Market Share of Recombinant Immunotherapeutics by Application (2011-2021)
Figure USA Recombinant Immunotherapeutics Sales Growth Rate by Application (2011-2021)
Table Amgen Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Amgen (2015 and 2016)
Table AstraZeneca Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Baxter Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Baxter (2015 and 2016)
Table Britannia Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Britannia (2015 and 2016)
Table Capricor Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Capricor (2015 and 2016)
Table CSL Behring Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of CSL Behring (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Grifols Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Grifols (2015 and 2016)
Table Ferring Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Ferring (2015 and 2016)
Table Janssen Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Janssen (2015 and 2016)
Table NeuroDerm Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of NeuroDerm (2015 and 2016)
Table Octapharma Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Octapharma (2015 and 2016)
Table Roche Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Roche (2015 and 2016)
Table Rhythm Metabolic Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Rhythm Metabolic (2015 and 2016)
Table scPharmceuticals Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of scPharmceuticals (2015 and 2016)
Table SteadyMed Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of SteadyMed (2015 and 2016)
Table Takeda Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Takeda (2015 and 2016)
Table United Therapeutics Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of United Therapeutics (2015 and 2016)
Table UCB Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of UCB (2015 and 2016)
Table US Worldmeds Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of US Worldmeds (2015 and 2016)